BioE communications office
5/3/2018 8:27:37 AM
Ostadhossein is developing a novel way to detect and treat bacterial infections in the heart through the use of antimicrobial nanoparticles. More generally, she works at the interface of materials engineering and bioengineering to develop Theranostic nanoparticles. These nanoparticles can diagnose the disease at early stage and then can act therapeutically to fight the disease.
The highly competitive AHA fellowships are designed to help initiate careers in cardiovascular and stroke research.